ATE528295T1 - Trisubstituierte 3,4-dihydro-1h-isochinolin- verbindung, verfahren zu ihrer herstellung und ihre anwendung - Google Patents

Trisubstituierte 3,4-dihydro-1h-isochinolin- verbindung, verfahren zu ihrer herstellung und ihre anwendung

Info

Publication number
ATE528295T1
ATE528295T1 AT08866627T AT08866627T ATE528295T1 AT E528295 T1 ATE528295 T1 AT E528295T1 AT 08866627 T AT08866627 T AT 08866627T AT 08866627 T AT08866627 T AT 08866627T AT E528295 T1 ATE528295 T1 AT E528295T1
Authority
AT
Austria
Prior art keywords
compound
isocinoline
dihydro
tris
substituted
Prior art date
Application number
AT08866627T
Other languages
English (en)
Inventor
Vries Andreas De
Doris Domin
Matthias Helms
Christoph Imboden
Ralf Koberstein
Zarghun Nazir
Wolfgang Skranc
Michael Stanek
Wilhelm Tschebull
Gerardus Verzijl
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE528295T1 publication Critical patent/ATE528295T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
AT08866627T 2007-12-28 2008-12-23 Trisubstituierte 3,4-dihydro-1h-isochinolin- verbindung, verfahren zu ihrer herstellung und ihre anwendung ATE528295T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2007055334 2007-12-28
PCT/IB2008/055509 WO2009083903A1 (en) 2007-12-28 2008-12-23 Trisubstituted 3,4-dihydro-1h-isoquinolin compound, process for its preparation, and its use

Publications (1)

Publication Number Publication Date
ATE528295T1 true ATE528295T1 (de) 2011-10-15

Family

ID=40394543

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08866627T ATE528295T1 (de) 2007-12-28 2008-12-23 Trisubstituierte 3,4-dihydro-1h-isochinolin- verbindung, verfahren zu ihrer herstellung und ihre anwendung

Country Status (11)

Country Link
US (1) US8247560B2 (de)
EP (1) EP2227455B1 (de)
JP (1) JP5829399B2 (de)
KR (1) KR101579992B1 (de)
CN (1) CN102083796B (de)
AT (1) ATE528295T1 (de)
CA (1) CA2709694C (de)
DK (1) DK2227455T3 (de)
ES (1) ES2375334T3 (de)
IL (1) IL206570A (de)
WO (1) WO2009083903A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101579991B1 (ko) 2007-12-28 2015-12-23 액테리온 파마슈티칼 리미티드 거울상이성질성의 삼치환된 3,4-디하이드로-이소퀴놀린 유도체의 제조 공정
WO2010095106A1 (en) * 2009-02-20 2010-08-26 Actelion Pharmaceuticals Ltd Solid forms of ( 2r) -2- { ( is ) -6, 7 -dimethoxy- 1- [2- (4-triflu0r0methyl-phenyl) -ethyl] -3, 4-dihydr0-1h -isoquinolin-2-yl} -n-methyl-2-phenyl-acetamide hydrochloride
TW201105635A (en) 2009-06-30 2011-02-16 Actelion Pharmaceuticals Ltd Process for the preparation of an enantiomerically pure trisubstituted 1,2,3,4-tetrahydroisoquinoline derivative
WO2013078413A1 (en) * 2011-11-22 2013-05-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulators of lipid storage

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3480714A (en) 1966-02-07 1969-11-25 Ciba Geigy Corp N-substituted isoquinolines as antiprotozoal agents
DD204917A1 (de) 1981-12-31 1983-12-14 Gerhard Kempter Verfahren zur herstellung phenylsubstituierter und benzkondensierter cycloalkylaminoacetanilide
JPS6153268A (ja) 1984-08-24 1986-03-17 Hokuriku Seiyaku Co Ltd アントラニルアミド誘導体
DD261158A1 (de) 1987-01-08 1988-10-19 Univ Halle Wittenberg Verfahren zur herstellung von 2-aminoalkyl-3,4-dihydro-4-oxo-7h-pyrrolo 2.3-d pyrimidinen
DD258817A1 (de) 1987-01-19 1988-08-03 Univ Halle Wittenberg Verfahren zur herstellung von 2-(aminoalkyl) -pyrimido-4,5'-5,4 pyrrolo 3,2-f 1,4 thiazepinderivaten
JPH07267961A (ja) 1994-03-30 1995-10-17 Taisho Pharmaceut Co Ltd ベンゾフロ［３，２−ｄピリミジン−４−オン誘導体
EP0916637B1 (de) 1995-12-06 2005-04-20 Japan Science and Technology Agency Verfahren zur herstellung optische aktive verbindungen
JPH1095766A (ja) 1996-09-19 1998-04-14 Sanwa Kagaku Kenkyusho Co Ltd アセトアミド誘導体、及びその用途
DE19952348A1 (de) 1998-12-19 2000-06-21 Degussa Liganden und Komplexe zur enantioselektiven Hydrierung
AU2001260113B2 (en) 2000-03-14 2006-04-06 Actelion Pharmaceuticals Ltd. 1,2,3,4-tetrahydroisoquinoline derivatives
EP1288202A4 (de) 2000-05-11 2003-07-02 Banyu Pharma Co Ltd N-acyltetrahydroisochinolin-derivate
WO2002051232A2 (en) 2000-12-27 2002-07-04 Actelion Pharmaceuticals Ltd. Novel benzazepines and related heterocyclic derivatives
GB0115862D0 (en) 2001-06-28 2001-08-22 Smithkline Beecham Plc Compounds
GB0130388D0 (en) 2001-12-19 2002-02-06 Smithkline Beecham Plc Compounds
KR20050114242A (ko) * 2003-03-26 2005-12-05 액테리온 파마슈티칼 리미티드 오렉신 수용체 길항제로서 이용되는테트라하이드로이소퀴놀릴 아세트아마이드 유도체
US7763638B2 (en) * 2004-03-01 2010-07-27 Actelion Pharmaceuticals Ltd. Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
TW200609239A (en) 2004-07-05 2006-03-16 Solvias Ag Process for preparing amines and a carboxamide thereof
CA2644010A1 (en) 2006-03-15 2007-09-20 Actelion Pharmaceuticals Ltd Tetrahydroisoquinoline derivatives to enhance memory function
CN101432285A (zh) 2006-04-26 2009-05-13 埃科特莱茵药品有限公司 作为食欲素受体拮抗剂的吡唑并-四氢吡啶衍生物

Also Published As

Publication number Publication date
EP2227455B1 (de) 2011-10-12
KR101579992B1 (ko) 2015-12-23
CN102083796B (zh) 2013-06-05
CA2709694C (en) 2016-04-05
EP2227455A1 (de) 2010-09-15
CA2709694A1 (en) 2009-07-09
WO2009083903A1 (en) 2009-07-09
IL206570A0 (en) 2010-12-30
IL206570A (en) 2014-07-31
US8247560B2 (en) 2012-08-21
DK2227455T3 (da) 2012-01-23
US20100010226A1 (en) 2010-01-14
JP5829399B2 (ja) 2015-12-09
ES2375334T3 (es) 2012-02-28
JP2011507944A (ja) 2011-03-10
KR20100110347A (ko) 2010-10-12
CN102083796A (zh) 2011-06-01

Similar Documents

Publication Publication Date Title
AT516600A5 (de) Herstellung von faktor h (fh) und fh-derivaten aus plasma
TR201903663T4 (tr) Ari̇loazol-2-i̇l si̇yanoeti̇lamino bi̇leşi̇kleri̇, bunlarin oluşturulmasi yöntemi̇ ve bunlarin kullanilmasi yöntemi̇.
EA201100666A1 (ru) Тиоамидные соединения, способ их получения и способ их применения
MX2010008713A (es) Derivados de 5,6-bisaril-2-piridina-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de la urotensina ii.
WO2008130953A3 (en) 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands
JO2673B1 (en) New diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
WO2009134531A3 (en) Total synthesis of salinosporamide a and analogs thereof
TN2010000219A1 (en) 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
WO2008052379A3 (en) Organic compounds
WO2007117591A3 (en) Total synthesis of salinosporamide a and analogs thereof
WO2009053545A3 (fr) Nouveau procede de synthese du (7-methoxy-l-naphtyl)acetonitrile et application a la synthese de l'agomelatine
EA200801893A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления
MX339840B (es) Moduladores de los receptores de 5-ht y metodos de uso de los mismos.
ATE536864T1 (de) Metoprololsuccinat tabletten mit verlängerter freisetzung und verfahren für deren herstellung
WO2008019030A8 (en) Modified azole compounds as antiinfective agents
ATE500226T1 (de) Aripiprazolhemifumarat und verfahren zu dessen herstellung
ATE528295T1 (de) Trisubstituierte 3,4-dihydro-1h-isochinolin- verbindung, verfahren zu ihrer herstellung und ihre anwendung
ATE465152T1 (de) Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten
ATE517900T1 (de) Heptarylen-und octarylentetracarbonsäurediimide und deren herstellung
ATE495160T1 (de) Kristallines 1-(cyclohexyloxycarbonyloxy)-ethyl 1-((2'-cyanobiphenyl-4-yl)-methyl)-2-ethoxy-1h- benzo-ädü-imidazol-7-carboxylat und verfahren zu seiner herstellung
DE502006008710D1 (de) Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
EA200870038A1 (ru) Способ получения аминов
WO2007080470A3 (en) A method for the purification of levetiracetam
MX2009007929A (es) Uso de un primer alergeno del grupo 2 de acaro de polvo de casa para tratar alergia a un segundo alergeno del grupo 2 de acaro de polvo de casa.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2227455

Country of ref document: EP